apoQlar medical

apoQlar medical is a forward-thinking medical software company dedicated to advancing healthcare through innovative virtual and mixed reality solutions. Founded in 2017, the company is committed to enhancing diagnostic precision, medical training, pre-operative planning, and patient education. Its HoloMedicine® technology empowers healthcare professionals to interact with 3D anatomical models, medical imaging, and simulated clinical scenarios in immersive virtual and mixed reality environments. Partnering with over 60 medical institutions worldwide, apoQlar medical designs technology that integrates seamlessly into clinical workflows, supporting both educators and clinicians in delivering higher quality, patient-centered care.

apoQlar medical operates in the Health Care and Medical Devices industries and is headquartered in Germany. The company recently secured a €10.00M Series A investment on 05 May 2024 from IFB Innovationsstarter GmbH and YZR Capital. This funding reflects investor confidence in apoQlar medical's mission and its potential to make significant advancements in digital healthcare. Through continuous collaboration with medical professionals, the company remains at the forefront of digital healthcare, ensuring that its solutions are clinically relevant and grounded in evidence-based practices.